Get Mobile to Save Time and Money

Health care is going mobile more than ever before and BioPlus is meeting this mobile challenge. By the end of this year, the mobile health app marketplace is expected to reach $26 billion as consumers increasingly turn to mobile application solutions to manage healthcare. Both patients and doctors are on-board with mobile health-related apps. A…

Turning Patients into Partners

Education opens minds. For patients, education often means the difference between adherence and non-adherence, which in turn determines the effectiveness of treatment. More than ever before, the health care community understands that an active partnership between patients and their health care team can empower patients and lead to better outcomes. The value of patients tapped…

Compliance in the Long Haul

Treating cancer is not always about a cure, sometimes it is more realistic to aim for controlling it long term as a chronic condition, which is a topic I explored earlier this year in Cancer Cure Vs. Control. It can be appropriate in some cases to control cancer with the goal of keeping it from…

Staying With the Patient

Medication adherence issues account for a significant portion of avoidable health care costs each year, through drug waste, treatment failure, and medical complications. Identifying ways to improve adherence ripples out positively throughout the health care system – benefiting the patient, payers, and all other key players. The pharmacy model at BioPlus Specialty Pharmacy focuses on…

MS and Sleep Disorders: What’s Next?

Recently, in my blog No Rest for Multiple Sclerosis, the prevalence of sleep disorders in those with multiple sclerosis was explored. Research in the Journal of Clinical Sleep Medicine indicates that approximately seven in every 10 people with multiple sclerosis appears to have a sleep disorder (such as obstructive sleep apnea, insomnia, or restless legs…

The Multiple Forms of Multiple Sclerosis

Elvin Montanez, Pharm.D., Senior Vice President at BioPlus Specialty Pharmacy Multiple sclerosis (MS) can be a tough disease to diagnose, since its symptoms can be mistaken for other conditions. Even after this autoimmune disease is ID’ed, that may not be the end of the story. Today, experts are starting to understand that there is more…

Making Decisions Together: Bringing Patients Into the Conversation

It is much more important to know what sort of a patient has a disease than what sort of a disease the patient has. — William Osler, M.D., 1913 Understanding the patient being treating can sometimes make more difference to treatment outcomes than knowing which disease is being treated. This nugget of wisdom, noted above…

A Special Touch

Brittany Trane knew that she’d really found the right place to work, soon after starting at BioPlus Specialty Pharmacy. One of the first patients she interacted with was Craig*, a patient with multiple sclerosis, who had been prescribed a new medication, called Rebif®. Rebif is used in the relapsing form of multiple sclerosis, to decrease…

Patient Adherence Goes Up as Out-of-Pocket Costs Go Down

The sky-rocketing cost of healthcare certainly isn’t breaking news. There is, however, an unfortunate trend related to these rising fees. As costs increasingly shift from payers onto the patients themselves – through greater out-of-pocket costs – finances for some patients hit a threshold which impacts adherence. In other words, some patients are simply getting priced…

Patient Assistance Lends a Hand

Specialty pharmacy continues to see annual increases in terms of U.S. spending on prescriptions for the treatment of complex or chronic diseases. URAC estimates that specialty drugs account for more than $50 billion of U.S. drug expenditures and comprises nearly 20 percent of the total pharmaceutical revenue. Specialty pharmacy is expected to make up approximately…

Better Cancer Screening Tests

Kimberly M. Hicks, Pharm.D., M.H.A., Clinical Pharmacy Specialist at BioPlus Specialty Pharmacy Screening tests are well-known and regularly used for several cancers, including breast cancer and cervical cancer; however, there are many other cancer sites that lack an effective early detection tool. That could soon be changing for lung cancer and prostate cancer. Lung cancer…

Hepatitis C Blues

Hepatitis C and depression tend to go hand-in-hand. For starters, there is the psychological impact of being diagnosed with a life-threatening disease. But with hepatitis C, the situation gets trickier. Certain medications used in the treatment of hepatitis C – which are needed to clear the virus and avoid cirrhosis, liver cancer, and death –…

“It’s Personal”

Guest Blog: Kimberly M. Hicks, Pharm.D., M.H.A., Clinical Pharmacy Specialist at BioPlus Specialty Pharmacy BioPlus is committed to supporting and raising awareness of the importance of breast cancer patient education, as well as the importance of early detection and prevention through annual mammograms. Cancer is class of diseases manifesting with abnormal cell growth. There are…

Eat Nuts for a Longer Life

Time to put nuts on the menu: a new study reveals that regularly including nuts in one’s diet slashes the risk of dying from any cause (that is, total mortality), as well as from the specific causes of cancer, heart disease, and respiratory disease. In March 2012 I shared with readers in my blog Going…

Blood Pressure-Alzheimer’s Connection

Every 68 seconds an American develops Alzheimer’s disease, so chances are that you already know someone battling this terrible disease. In all, there are an estimated 5.2 million Americans currently living with Alzheimer’s disease. Today there are new tantalizing clues that controlling blood pressure could play a role in keeping Alzheimer’s at bay. A cure…

Overcoming Lupus Medication Compliance Challenges

The health challenges of lupus can be debilitating, yet two out of three lupus patients cared under Medicaid do not fully comply with their medication treatment plan. This new statistic emerged from a presentation at the annual meeting of the American College of Rheumatology/Association of Rheumatology Health Professionals. Poorly controlled lupus can lead to disease…

Expensive Out-of-Pocket Costs: The Latest Treatment Side Effect?

High health care costs leading to financial strain should be considered a side effect of treating a disease for some patients, posits Peter Ubel, M.D., Professor at Duke University, and his colleagues in a provocative new article in the New England Journal of Medicine. Most physicians speak openly with patients about a new chemotherapy medication…

Prescribers: Want Your Patients Treated? Then Don’t Hand Them a Prescription

When it comes to the treatment of tricky health conditions with specialty medications – such as Humira or Enbrel for rheumatoid arthritis, Vivitrol for alcohol dependence, or medications to treat hepatitis C – patients are more likely to start treatment if their prescribing physician doesn’t hand over a paper prescription. How so? There are three…